$27.06
+0.41 (+1.54%)
As of Feb 24, 1:04 PM ET ·
Analyst Consensus
Hold
33
Analysts
Very High
Coverage
Buy 15 45%
Hold 17 52%
Sell 1 3%
Price Target
Analyst Price Target +25.3% upside
Low Target $24.03
Average Target $33.90
High Target $39.81
Current Price $27.06
Current
$27.06
Target
$33.90
$24.03 $33.90 avg $39.81
Scenario Analysis
Bear Case
$24.03
-11.2%
Low target
Base Case
$33.90
+25.3%
Avg target
Bull Case
$39.81
+47.1%
High target
Risk/Reward
4.2x
Highly favorable
Price in Context
52-Week High
$27.94
-3.1% from high
52-Week Low
$20.92
+29.4% from low
50-Day SMA
$25.92
+4.4% vs SMA
200-Day SMA
$24.89
+8.7% vs SMA
RSI (14)
57.0
Neutral
Target vs 52W High
$33.90
+21.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Buy 37 73% $1,330.33 +25.7%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +21.8%
MRK
Merck & Co. Inc.
Buy 34 62% $159.27 +28.6%
PFE
Pfizer Inc.
Hold 33 45% $33.90 +25.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +184.9%
ZTS
Zoetis Inc
Buy 24 67% $209.87 +65.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -18.8%
VTRS
Viatris Inc
Buy 18 61% $122.82 +670.0%